At a glance
- Originator Merck Frosst
- Class Analgesics; Antipyretics; Antirheumatics
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 18 Jan 2000 New profile
- 18 Jan 2000 No-Development-Reported for Inflammation in Canada (Unknown route)